We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
IDEX Gears Up to Report Q1 Earnings: What's in the Cards?
Read MoreHide Full Article
Key Takeaways
IDEX expects Q1 EPS of $1.78 and revenues of $835.2M, up 1.7% and 2.6%, respectively YoY.
IEX's Health & Science unit seen rising 9.6%, supported by pharma and data center demand.
Weak FSDP segment and rising operating costs are likely to have weighed on IDEX's bottom-line performance.
IDEX Corporation (IEX - Free Report) is scheduled to release first-quarter 2026 results on April 29, before market open.
The Zacks Consensus Estimate for first-quarter earnings has remained steady in the past 60 days. The company has an impressive earnings surprise history, having outperformed the consensus estimate in each of the preceding four quarters, the average surprise being 4.6%.
The consensus estimate for revenues is pegged at $835.2 million, indicating an increase of 2.6% from the prior-year quarter’s figure. The consensus estimate for adjusted earnings is pinned at $1.78 per share, indicating an increase of 1.7% from the year-ago quarter’s number.
Let's see how things have shaped up for IDEX this earnings season.
Factors to Note Ahead of IDEX’s Results
The Health & Science Technologies (HST) segment is expected to have benefited from strong momentum in the pharma, life science, semiconductor consumables and data center businesses. Also, strength in the aerospace and defense markets is expected to have aided the segment’s performance in the first quarter. The consensus estimate for HST segment’s revenues is pegged at $375 million, indicating an increase of 9.6% year over year.
An increase in demand for products across the municipal water business is expected to have aided the Fluid & Metering Technologies (FMT) segment. Higher volume in the industrial business is likely to have been a tailwind as well. The consensus estimate for FMT segment’s revenues is pegged at $295 million, indicating a growth of 1.4% year over year.
IDEX has remained focused on expanding its product offerings and market presence through buyouts, which is expected to have boosted its top line. In July 2025, the company acquired Micro-LAM, Inc. (Micro-LAM), which expanded IDEX’s optics technologies offerings. Also, the acquisition of Mott Corp. and its subsidiaries (Mott) in September 2024 expanded the company’s expertise in applied materials science technology capabilities across high-value end markets.
However, the Fire & Safety/Diversified Products (FSDP) segment is expected to have put up a weak show due to softness in the dispensing business arising from the unfavorable timing of dispensing projects in emerging markets and slower equipment replenishment. Also, weakness in the fire OEM business and decrease in demand for rescue tools have also been acting as a headwind for the segment’s performance. The consensus estimate for the segment’s revenues is pegged at $184 million, in line with the year-ago quarter figure.
The escalating costs and operating expenses, due to increasing employee-related costs and professional services spending, are likely to have weighed on IEX’s bottom line in the to-be-reported quarter.
Our proven model does not conclusively predict an earnings beat for IEX this time around. The combination of a positive Earnings ESP and a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold) increases the odds of an earnings beat, which is not the case here, as elaborated below.
Earnings ESP: IEX has an Earnings ESP of -0.85% as the Zacks Consensus Estimate is pegged at $.78 per share, higher than the Most Accurate Estimate of $1.76. You can uncover the best stocks before they’re reported with our Earnings ESP Filter.
Zacks Rank: IEX presently carries a Zacks Rank #4 (Sell).
Here are some companies, which according to our model, have the right combination of elements to beat on earnings in this reporting cycle.
RBC Bearings (RBC - Free Report) has an Earnings ESP of +5.80% and a Zacks Rank of 2 at present. The company is slated to release first-quarter 2026 results on May 15.
RBC Bearings’ earnings surpassed the Zacks Consensus Estimate in each of the trailing four quarters, the average surprise being 5.3%.
Stanley Black & Decker (SWK - Free Report) has an Earnings ESP of +5.38% and a Zacks Rank of 3 at present. The company is scheduled to release first-quarter 2026 results on April 29.
Stanley Black & Decker’s earnings surpassed the Zacks Consensus Estimate in each of the preceding four quarters, the average surprise being 56.4%.
Illinois Tool Works (ITW - Free Report) has an Earnings ESP of +0.30% and a Zacks Rank of 3 at present. The company is slated to release first-quarter 2026 results on April 30.
Illinois Tool’s earnings surpassed the Zacks Consensus Estimate in each of the trailing four quarters, the average surprise being 2.1%.
Zacks' 7 Best Strong Buy Stocks (New Research Report)
Valued at $99, click below to receive our just-released report
predicting the 7 stocks that will soar highest in the coming month.
View the Zacks #1 Rank List
Image: Bigstock
IDEX Gears Up to Report Q1 Earnings: What's in the Cards?
Key Takeaways
IDEX Corporation (IEX - Free Report) is scheduled to release first-quarter 2026 results on April 29, before market open.
The Zacks Consensus Estimate for first-quarter earnings has remained steady in the past 60 days. The company has an impressive earnings surprise history, having outperformed the consensus estimate in each of the preceding four quarters, the average surprise being 4.6%.
The consensus estimate for revenues is pegged at $835.2 million, indicating an increase of 2.6% from the prior-year quarter’s figure. The consensus estimate for adjusted earnings is pinned at $1.78 per share, indicating an increase of 1.7% from the year-ago quarter’s number.
Let's see how things have shaped up for IDEX this earnings season.
Factors to Note Ahead of IDEX’s Results
The Health & Science Technologies (HST) segment is expected to have benefited from strong momentum in the pharma, life science, semiconductor consumables and data center businesses. Also, strength in the aerospace and defense markets is expected to have aided the segment’s performance in the first quarter. The consensus estimate for HST segment’s revenues is pegged at $375 million, indicating an increase of 9.6% year over year.
An increase in demand for products across the municipal water business is expected to have aided the Fluid & Metering Technologies (FMT) segment. Higher volume in the industrial business is likely to have been a tailwind as well. The consensus estimate for FMT segment’s revenues is pegged at $295 million, indicating a growth of 1.4% year over year.
IDEX has remained focused on expanding its product offerings and market presence through buyouts, which is expected to have boosted its top line. In July 2025, the company acquired Micro-LAM, Inc. (Micro-LAM), which expanded IDEX’s optics technologies offerings. Also, the acquisition of Mott Corp. and its subsidiaries (Mott) in September 2024 expanded the company’s expertise in applied materials science technology capabilities across high-value end markets.
However, the Fire & Safety/Diversified Products (FSDP) segment is expected to have put up a weak show due to softness in the dispensing business arising from the unfavorable timing of dispensing projects in emerging markets and slower equipment replenishment. Also, weakness in the fire OEM business and decrease in demand for rescue tools have also been acting as a headwind for the segment’s performance. The consensus estimate for the segment’s revenues is pegged at $184 million, in line with the year-ago quarter figure.
The escalating costs and operating expenses, due to increasing employee-related costs and professional services spending, are likely to have weighed on IEX’s bottom line in the to-be-reported quarter.
IDEX Corporation Price and EPS Surprise
IDEX Corporation price-eps-surprise | IDEX Corporation Quote
Earnings Whisper
Our proven model does not conclusively predict an earnings beat for IEX this time around. The combination of a positive Earnings ESP and a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold) increases the odds of an earnings beat, which is not the case here, as elaborated below.
Earnings ESP: IEX has an Earnings ESP of -0.85% as the Zacks Consensus Estimate is pegged at $.78 per share, higher than the Most Accurate Estimate of $1.76. You can uncover the best stocks before they’re reported with our Earnings ESP Filter.
Zacks Rank: IEX presently carries a Zacks Rank #4 (Sell).
You can see the complete list of today’s Zacks #1 Rank stocks here.
Stocks to Consider
Here are some companies, which according to our model, have the right combination of elements to beat on earnings in this reporting cycle.
RBC Bearings (RBC - Free Report) has an Earnings ESP of +5.80% and a Zacks Rank of 2 at present. The company is slated to release first-quarter 2026 results on May 15.
RBC Bearings’ earnings surpassed the Zacks Consensus Estimate in each of the trailing four quarters, the average surprise being 5.3%.
Stanley Black & Decker (SWK - Free Report) has an Earnings ESP of +5.38% and a Zacks Rank of 3 at present. The company is scheduled to release first-quarter 2026 results on April 29.
Stanley Black & Decker’s earnings surpassed the Zacks Consensus Estimate in each of the preceding four quarters, the average surprise being 56.4%.
Illinois Tool Works (ITW - Free Report) has an Earnings ESP of +0.30% and a Zacks Rank of 3 at present. The company is slated to release first-quarter 2026 results on April 30.
Illinois Tool’s earnings surpassed the Zacks Consensus Estimate in each of the trailing four quarters, the average surprise being 2.1%.